DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: The RESPONSE Trial

Information source: Incyte Corporation
Information obtained from ClinicalTrials.gov on December 08, 2011
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Polycythemia Vera

Intervention: INC424 tablets (Drug); Best Available Therapy (BAT) (Other)

Phase: Phase 3

Status: Recruiting

Sponsored by: Incyte Corporation

Official(s) and/or principal investigator(s):
Srdan Verstovsek, MD,PhD, Study Director, Affiliation: M.D. Anderson Cancer Center

Overall contact:
William Garrett, MBA, Phone: 302-498-6987, Email: wgarrett@incyte.com

Summary

This pivotal phase III trial (CINC424B2301) is designed to compare the efficacy and safety of INC424 to Best Available Therapy (BAT) in subjects with polycythemia vera (PV) who are resistant to or intolerant of hydroxyurea (HU).

Clinical Details

Official title: Randomized, Open Label, Multicenter Phase III Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 Tablets Versus Best Available Care

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Proportion of subjects achieving a response at Week 32. 'Response' is defined as having achieved both: (1) the absence of protocol-defined phlebotomy eligibility and (2) a ≥ 35% reduction from baseline in spleen volume as determined by imaging

Secondary outcome:

Proportion of subjects achieving complete hematologic remission at Week 32.

Proportion of all randomized subjects who both achieve the Week 32 primary response endpoint and maintain response for ≥ 48 weeks from the time that response was initially documented.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Subjects diagnosed with PV for at least 24 weeks prior to screening according to the

2008 World Health Organization criteria

- Subjects resistant to or intolerant of hydroxyurea

- Subjects with a phlebotomy requirement

- Subjects with a palpable splenomegaly ≥ 5 cm below the costal margin

- Subjects with elevated white blood cell and/or platelet counts

- Subjects with an ECOG performance status of 0, 1 or 2

Exclusion Criteria:

- Women who are pregnant or nursing

- Subjects with inadequate liver or renal function

- Subjects with significant bacterial, fungal, parasitic, or viral infection requiring

treatment

- Subjects with an active malignancy within the past 5 years, excluding specific skin

cancers

- Subjects with known active hepatitis or HIV positivity

- Subjects who have previously received treatment with a JAK inhibitor

- Subjects being treated with any investigational agent

Locations and Contacts

William Garrett, MBA, Phone: 302-498-6987, Email: wgarrett@incyte.com

Brisbane, Australia; Not yet recruiting

Frankston, Australia; Not yet recruiting

Parkville, Australia; Not yet recruiting

Antwerp, Belgium; Recruiting

Brugge, Belgium; Recruiting

Bruxelles, Belgium; Not yet recruiting

Gent, Belgium; Recruiting

Haine-saint-Paul, Belgium; Not yet recruiting

Leuven, Belgium; Not yet recruiting

Yvoir, Belgium; Recruiting

Hamilton, Canada; Not yet recruiting

Montreal, Canada; Recruiting

Toronto, Canada; Not yet recruiting

Avignon, France; Not yet recruiting

Brest, France; Not yet recruiting

Creteil, France; Not yet recruiting

Lens, France; Not yet recruiting

Lille, France; Not yet recruiting

Limoges, France; Not yet recruiting

Nimes, France; Not yet recruiting

Paris, France; Not yet recruiting

Pessac, France; Not yet recruiting

Politiers, France; Not yet recruiting

Aachen, Germany; Recruiting

Berlin, Germany; Recruiting

Budapest, Germany; Recruiting

Freiburg, Germany; Recruiting

Hamburg, Germany; Recruiting

Jena, Germany; Recruiting

Kiel, Germany; Recruiting

Magdeburg, Germany; Recruiting

Mannheim, Germany; Not yet recruiting

Minden, Germany; Recruiting

Munchen, Germany; Recruiting

Szeged, Germany; Recruiting

Szombathely, Germany; Recruiting

Ulm, Germany; Recruiting

Wurzburg, Germany; Recruiting

Debrecen, Hungary; Recruiting

Kecskemet, Hungary; Recruiting

Szolnok, Hungary; Recruiting

Bari, Italy; Not yet recruiting

Bergamo, Italy; Not yet recruiting

Bolonga, Italy; Not yet recruiting

Firenze, Italy; Recruiting

Milano, Italy; Not yet recruiting

Napoli, Italy; Not yet recruiting

Orbassano, Italy; Not yet recruiting

Pavia, Italy; Not yet recruiting

Reggio Calabria, Italy; Not yet recruiting

Roma, Italy; Not yet recruiting

Varese, Italy; Not yet recruiting

Vicenza, Italy; Not yet recruiting

Seoul, Korea, Republic of; Recruiting

Enschede, Netherlands; Not yet recruiting

Rotterdam, Netherlands; Not yet recruiting

Moscow, Russian Federation; Not yet recruiting

St. Petersburg, Russian Federation; Not yet recruiting

Barcelona, Spain; Recruiting

La Coruna, Spain; Not yet recruiting

La Laguna/Str cruz de Tenerifa, Spain; Not yet recruiting

Las Palmas de Gran Canaria, Spain; Not yet recruiting

Madrid, Spain; Recruiting

Majadanonda, Spain; Recruiting

Malaga, Spain; Recruiting

Pamplona, Spain; Not yet recruiting

Salamanca, Spain; Not yet recruiting

Santiago de Compostela, Spain; Recruiting

Valencia, Spain; Not yet recruiting

Ankara, Turkey; Not yet recruiting

Istanbul, Turkey; Not yet recruiting

Izmir, Turkey; Not yet recruiting

Cardiff, United Kingdom; Recruiting

Leeds, United Kingdom; Not yet recruiting

London, United Kingdom; Recruiting

Nottingham, United Kingdom; Not yet recruiting

Birmingham, Alabama, United States; Recruiting

Chandler, Arizona, United States; Recruiting

Scottsdale, Arizona, United States; Recruiting

La Jolla, California, United States; Recruiting

Pomona, California, United States; Recruiting

Sacramento, California, United States; Recruiting

San Diego, California, United States; Recruiting

Denver, Colorado, United States; Not yet recruiting

Bridgeport, Connecticut, United States; Recruiting

New Haven, Connecticut, United States; Not yet recruiting

Boynton Beach, Florida, United States; Recruiting

Ft Meyers, Florida, United States; Recruiting

Lake Worth, Florida, United States; Not yet recruiting

Miami, Florida, United States; Recruiting

Winter Park, Florida, United States; Recruiting

Barrington, Illinois, United States; Recruiting

Chicago, Illinois, United States; Recruiting

Joliet, Illinois, United States; Not yet recruiting

Quincy, Illinois, United States; Not yet recruiting

Springfield, Illinois, United States; Recruiting

Sioux City, Iowa, United States; Recruiting

Lafayette, Louisiana, United States; Recruiting

Scarborough, Maine, United States; Recruiting

Baltimore, Maryland, United States; Recruiting

Columbia, Maryland, United States; Recruiting

Metheun, Massachusetts, United States; Recruiting

East Lansing, Michigan, United States; Not yet recruiting

Southfield, Michigan, United States; Recruiting

Duluth, Minnesota, United States; Not yet recruiting

Jefferson City, Missouri, United States; Recruiting

Saint Louis, Missouri, United States; Recruiting

Omaha, Nebraska, United States; Recruiting

Henderson, Nevada, United States; Recruiting

Morristown, New Jersey, United States; Recruiting

Phillipsburg, New Jersey, United States; Not yet recruiting

Somerville, New Jersey, United States; Recruiting

Albuquerque, New Mexico, United States; Not yet recruiting

Armonk, New York, United States; Recruiting

Lake Success, New York, United States; Recruiting

Mineola, New York, United States; Recruiting

New Rochelle, New York, United States; Not yet recruiting

New York, New York, United States; Recruiting

Valhalla, New York, United States; Recruiting

Goldsboro, North Carolina, United States; Recruiting

Greenville, North Carolina, United States; Not yet recruiting

Bismarck, North Dakota, United States; Recruiting

Canton, Ohio, United States; Recruiting

Cleveland, Ohio, United States; Not yet recruiting

Middletown, Ohio, United States; Recruiting

Portland, Oregon, United States; Not yet recruiting

Bethlehem, Pennsylvania, United States; Not yet recruiting

Pittsburgh, Pennsylvania, United States; Not yet recruiting

Upland, Pennsylvania, United States; Not yet recruiting

Charleston, South Carolina, United States; Recruiting

Memphis, Tennessee, United States; Not yet recruiting

Nashville, Tennessee, United States; Recruiting

Corpus Christi, Texas, United States; Recruiting

Houston, Texas, United States; Recruiting

San Antonio, Texas, United States; Recruiting

Salt Lake City, Utah, United States; Not yet recruiting

Charlottesville, Virginia, United States; Recruiting

Roanoke, Virginia, United States; Recruiting

Seattle, Washington, United States; Recruiting

Milwaukee, Wisconsin, United States; Not yet recruiting

Additional Information

Starting date: October 2010
Last updated: December 5, 2011

Page last updated: December 08, 2011

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012